sorafenib has been researched along with antrocin in 1 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (antrocin) | Trials (antrocin) | Recent Studies (post-2010) (antrocin) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 7 | 0 | 7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, MY; Chu, YC; Hsieh, MS; Hsu, CH; Ma, HP; Ong, JR; Setiawan, SA; Tzeng, DTW; Tzeng, YM; Wu, ATH; Yeh, CT | 1 |
1 other study(ies) available for sorafenib and antrocin
Article | Year |
---|---|
Ovatodiolide and antrocin synergistically inhibit the stemness and metastatic potential of hepatocellular carcinoma via impairing ribosome biogenesis and modulating ERK/Akt-mTOR signaling axis.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Diterpenes; Humans; Lactones; Liver Neoplasms; Mice; Neoplastic Stem Cells; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Ribosomes; Sesquiterpenes; Sorafenib; TOR Serine-Threonine Kinases | 2023 |